Lauren Wright
Conceive Gynaecology and Fertility Hospital, UAEPresentation Title:
Microbiome-mediated model for reproductive longevity
Abstract
Current frontline treatment for primary infertility in 1 in 5 women relies on hormonal interventions, with long-term fertility effects unknown. Declining fertility rates may lead to a critical global population low within 200 years. However, preventative approaches targeting cytokine-induced ovarian damage remain underdeveloped. Recent evidence suggests that reproductive longevity may be enhanced by modulating the microbiome. This grant will investigate microbiome-mediated interventions to mitigate chronic inflammation and its impact on ovarian health. Using fertility data and biomarkers from hormonally optimized populations, we will analyze modifiable gut microbiome and lifestyle factors. Our goal is to democratize access to reproductive longevity protocols through partner institutions, providing clinicians with scalable tools for personalized fertility and longevity planning. By integrating AI-driven data analysis, this project addresses gender disparities in fertility care, ensuring equitable access to evidence-based, non-hormonal protocols. Findings will be translated into Continuing Education courses and published to guide Microbiome-Mediated Interventions for Reproductive Longevity. By focusing on retrieving one high-quality egg per cycle, this approach aligns with natural reproductive physiology, reduces risks, and improves overall health, economic participation, and decision-making autonomy for women.
Biography
Lauren Wright is a clinician, researcher, and serial entrepreneur focused on microbiome-mediated therapeutics to improve female reproductive longevity and reduce IVF complications. For the last 10 years, Lauren has been passionate about optimizing wellness by integrating preventative primary health care and research. As a nurse practitioner studying the gut microbiome of preterm infants, she discovered that babies who weren't being given breast milk were suffering fatal complications. From this gap in industry, she created a solution that would give all babies the ability to have breast milk, and support prolonged breastfeeding.
Determined to solve this problem while working as a PhD student, focused on psychoneuroimmunology, she conducted clinical research in a 4 year National Institutes of Research Study with a 99% recruitment and retention rate and simultaneously pioneered 5 years of R&D resulting in patenting an innovative infant feeding solution funded by the leading U.S. government science agency that backs NASA, NSF, and garnering support from health insurance companies and Fortune 500 industry leaders, including Johnson & Johnson. Her leadership experience includes consulting for the fastest growing tele-health companies such as 'For Hims & Hers' in the top 3% of providers, as well as for Google spinout 'Forward', reporting to former CFO of Tesla, Jason Wheeler, on how to optimize patient care and provider operations. As CEO, she led interdisciplinary teams to successfully achieve the safest, slowest milk flow since bottles were invented 200 years ago with a capital efficient methodology as Principal Investigator, raising ~$1 Million in grants and investments.
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Program Enquiry
gynecologycongress@scientexconferences.org
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
gynecologycongress@scientexconferences.org
Our Social Presence
Call us at
USA :(+1) 267 766 9331